CHRNA9 Antikörper
Kurzübersicht für CHRNA9 Antikörper (ABIN7112723)
Target
Alle CHRNA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- cholinergic receptor, nicotinic, alpha 9
-
Isotyp
- IgG
-
-
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42), (N-Term) antibody
CHRNA9 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB46802 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 26-240) antibodyCHRNA9 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 139-221) antibodyCHRNA9 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 8E4 unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (AA 8-42) antibodyCHRNA9 Reaktivität: Human WB, IHC, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte, Hund, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Maus, Hund, Rind (Kuh), Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Huhn WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) (N-Term) antibodyCHRNA9 Reaktivität: Human, Maus, Ratte, Hund, Rind (Kuh), Pferd, Kaninchen, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB: 1:500-1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Andere Bezeichnung
- CHRNA9
-
Hintergrund
- Synonyms:NACHRA9 Background:Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane(PubMed:11752216, PubMed:25282151). The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane(PubMed:11752216, PubMed:25282151). In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion(PubMed:11021840).
-
Molekulargewicht
- 50-55 kDa
-
Gen-ID
- 55584
-
UniProt
- Q9UGM1
-
Pathways
- Sensory Perception of Sound
Target
-
